CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo aims to stall advanced prostate cancer
Disease control OngoingThis phase 3 trial tests whether adding the drug niraparib to standard treatment (abiraterone and prednisone) can slow the growth of metastatic prostate cancer that no longer responds to hormone therapy. About 765 men with specific genetic changes are taking part. The study compa…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Prostate cancer drugs may cloud your mind: new study investigates
Knowledge-focused OngoingThis study looks at how certain hormone therapies for advanced prostate cancer might affect memory, thinking, and brain structure. Researchers will use brain scans and thinking tests in 100 men to track changes over time. The goal is to understand which patients are more likely t…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC